Jennifer N Brudno

7PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 21, 2025
Survival after anti-CD19 CAR T-cell therapy for B-cell non-Hodgkin lymphoma and CLL with 10 years of follow-up.

Tatyana Gavrilova, Lori McIntyre, Stephanie L Goff

|Jun 03, 2024
Chimeric antigen receptor T cell therapy for autoimmune disease.

James B Chung, Jennifer N Brudno, Dominic Borie

|May 20, 2024
Current understanding and management of CAR T cell-associated toxicities.

Jennifer N Brudno, James N Kochenderfer

|Nov 08, 2023
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial.

Jennifer N Brudno, Danielle A Natrakul, Jeremiah Karrs

|Jul 15, 2023
Limited utility of chimeric antigen receptor (CAR) T-cell retreatment: experience with a human anti-CD19 CAR.

Jennifer N Brudno, James N Kochenderfer

|Jan 23, 2023
Off-the-shelf CAR T cells for multiple myeloma.

Jennifer N Brudno, James N Kochenderfer

Pageof 2

Frequent Collaborators

4 joint publications

James N Kochenderfer

1 joint publications

Marcela V Maus

1 joint publications

Michael R Bishop

1 joint publications

Marco L Davila